Diana I Brixner

机构：University of Utah · ORCID：0000-0001-6637-6359

发表论文 295 篇 · 总被引 3760 次 · h-index 35

代表论文

• The Rise of Prescription Digital Therapeutics in Behavioral Health (2022 · Advances in Therapy · 被引 34)
• Cancer incidence in immunocompromised patients: a single-center cohort study (2023 · BMC Cancer · 被引 29)
• Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States (2023 · Journal of Managed Care & Specialty Pharmacy · 被引 17)
• Overcoming barriers to HIV prevention: population health considerations on optimizing PrEP access (2024 · The American Journal of Managed Care · 被引 12)
• Addressing the Burden of Multiple Daily Insulin Injections in Type 2 Diabetes with Insulin Pump Technology: A Narrative Review (2024 · Diabetes Therapy · 被引 12)
• Gastrointestinal adverse effects associated with the use of intravenous oliceridine compared with intravenous hydromorphone or fentanyl in acute pain management utilizing adjusted indirect treatment comparison methods (2024 · Journal of Comparative Effectiveness Research · 被引 12)